{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:05:50Z","timestamp":1783526750589,"version":"3.55.0"},"reference-count":153,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>Lung cancer is the second most common cancer and the primary cause of cancer-related death in both men and women worldwide. Due to diagnosis at an advanced stage, it is associated with high mortality in the majority of patients. At present, various treatment approaches are available, such as chemotherapy, surgery, and radiotherapy, but all these approaches usually cause serious side effects like degeneration of normal cells, bone marrow depression, alopecia, extensive vomiting, etc. To overcome the aforementioned problems, researchers have focused on the alternative therapeutic approach in which various natural compounds are reported, which possessed anti-lung cancer activity. Phytocompounds exhibit their anti lung cancer activity via targeting various cell-signaling pathways, apoptosis and cell cycle arrest, and by regulating antioxidant status and detoxification. Apart from the excellent anti-cancer activity, clinical administration of phytocompounds is confined because of their high lipophilicity and low bioavailability. Therefore, researchers show their concern in the development of a stable, safe and effective approach of treatment with minimal side effects by the development of nanoparticle-based delivery of these phytocompounds to the target site. Targeted delivery of phytocompound through nanoparticles overcomes the aforementioned problems. In this article, the molecular mechanism of phytocompounds, their emerging combination therapy, and their nanoparticles-based delivery systems in the treatment of lung cancer have been discussed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871520621666210708123750","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T07:22:58Z","timestamp":1625815378000},"page":"668-686","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-Based Systems for Effective Management of Lung Cancer"],"prefix":"10.2174","volume":"22","author":[{"given":"Mahak","family":"Fatima","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Kashif","family":"Iqubal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashif","family":"Iqubal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, New Delhi-110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf Jamal","family":"Gilani","sequence":"additional","affiliation":[{"name":"Department of Basic Health Science, Preparatory Year, Princess Nourah Bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Habibur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Banani, Dhaka-1213, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-7298","authenticated-orcid":true,"given":"Md.","family":"Rizwanullah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3892\/ijo.2015.2915","volume":"46","author":"Hung J.Y.","year":"2015","unstructured":"Hung J.Y.; Chang W.A.; Tsai Y.M.; Hsu Y.L.; Chiang H.H.; Chou S.H.; Huang M.S.; Kuo P.L.; Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene induced human non small cell lung cancer bone metastasis. Int J Oncol 2015,46(5),1985-1993","journal-title":"Int J Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.07.003","volume":"70","author":"Iqbal M.A.","year":"2019","unstructured":"Iqbal M.A.; Arora S.; Prakasam G.; Calin G.A.; Syed M.A.; MicroRNA in lung cancer: Role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med 2019,70,3-20","journal-title":"Mol Aspects Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/bmb\/ldq023","volume":"95","author":"MacKinnon A.C.","year":"2010","unstructured":"MacKinnon A.C.; Kopatz J.; Sethi T.; The molecular and cellular biology of lung cancer: Identifying novel therapeutic strategies. Br Med Bull 2010,95,47-61","journal-title":"Br Med Bull"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/bmj.38142.554479.AE","volume":"328","author":"Doll R.","year":"2004","unstructured":"Doll R.; Peto R.; Boreham J.; Sutherland I.; Mortality in relation to smoking: 50 years\u2019 observations on male British doctors. BMJ 2004,328(7455),1519","journal-title":"BMJ"},{"key":"ref=5","first-page":"6951","volume":"48","author":"Garfinkel L.","year":"1988","unstructured":"Garfinkel L.; Stellman S.D.; Smoking and lung cancer in women: Findings in a prospective study. Cancer Res 1988,48(23),6951-6955","journal-title":"Cancer Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"7200","DOI":"10.1021\/acsnano.0c02207","volume":"14","author":"Perry J.L.","year":"2020","unstructured":"Perry J.L.; Tian S.; Sengottuvel N.; Harrison E.B.; Gorentla B.K.; Kapadia C.H.; Cheng N.; Luft J.C.; Ting J.P.; DeSimone J.M.; Pecot C.V.; Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung cancer. ACS Nano 2020,14(6),7200-7215","journal-title":"ACS Nano"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1164\/rccm.201901-0096OC","volume":"201","author":"Brims F.J.H.","year":"2020","unstructured":"Brims F.J.H.; Kong K.; Harris E.J.A.; Sodhi-Berry N.; Reid A.; Murray C.P.; Franklin P.J.; Musk A.B.; de Klerk N.H.; Pleural plaques and the risk of lung cancer in asbestos-exposed subjects. Am J Respir Crit Care Med 2020,201(1),57-62","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061461","volume":"20","author":"Kinoshita T.","year":"2019","unstructured":"Kinoshita T.; Goto T.; Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: A review. Int J Mol Sci 2019,20(6),1-16","journal-title":"Int J Mol Sci"},{"key":"ref=9","first-page":"197","volume":"39","author":"Panov S.Z.","year":"2005","unstructured":"Panov S.Z.; Molecular biology of the lung cancer. Radiol Oncol 2005,39(3),197-210","journal-title":"Radiol Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fonc.2017.00193","volume":"7","author":"Inamura K.","year":"2017","unstructured":"Inamura K.; Lung cancer: Understanding its molecular pathology and the 2015 WHO classification. Front Oncol 2017,7,193","journal-title":"Front Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.biotechadv.2016.04.002","volume":"34","author":"Xie J.","year":"2016","unstructured":"Xie J.; Yang Z.; Zhou C.; Zhu J.; Lee R.J.; Teng L.; Nanotechnology for the delivery of phytochemicals in cancer therapy. Biotechnol Adv 2016,34(4),343-353","journal-title":"Biotechnol Adv"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/1061186X.2017.1408115","volume":"26","author":"Rizwanullah M.","year":"2018","unstructured":"Rizwanullah M.; Amin S.; Mir S.R.; Fakhri K.U.; Rizvi M.M.A.; Phytochemical based nanomedicines against cancer: Current status and future prospects. J Drug Target 2018,26(9),731-752","journal-title":"J Drug Target"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","volume":"65","author":"Maeda H.","year":"2013","unstructured":"Maeda H.; Nakamura H.; Fang J.; The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 2013,65(1),71-79","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129936","volume":"1865","author":"Rizwanullah M.","year":"2021","unstructured":"Rizwanullah M.; Ahmad M.Z.; Garg A.; Ahmad J.; Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochim Biophys Acta, Gen Subj 2021,1865(9)","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00914037.2020.1869737","volume":"70","author":"Ahmad M.Z.","year":"2021","unstructured":"Ahmad M.Z.; Rizwanullah M.; Ahmad J.; Alasmary M.Y.; Akhter M.H.; Abdel-Wahab B.A.; Warsi M.H.; Haque A.; Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy. Int J Polym Mater Polym Biomater 2021,70,1-22","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/pharmaceutics13010024","volume":"13","author":"Alshehri S.","year":"2020","unstructured":"Alshehri S.; Imam S.S.; Rizwanullah M.; Akhter S.; Mahdi W.; Kazi M.; Ahmad J.; Progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: Preclinical promise and translational challenges. Pharmaceutics 2020,13(1),24","journal-title":"Pharmaceutics"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2025636","volume":"2019","author":"Hou W.","year":"2019","unstructured":"Hou W.; Hu S.; Li C.; Ma H.; Wang Q.; Meng G.; Guo T.; Zhang J.; Cigarette smoke induced lung barrier dysfunction, EMT, and tissue remodeling: A possible link between COPD and lung cancer. BioMed Res Int 2019,2019","journal-title":"BioMed Res Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1002\/ijc.32279","volume":"145","author":"Duan W.","year":"2019","unstructured":"Duan W.; Gao L.; Kalvala A.; Aguila B.; Brooks C.; Mo X.; Ding H.; Shilo K.; Otterson G.A.; Villalona-Calero M.A.; Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice. Int J Cancer 2019,145(9),2418-2426","journal-title":"Int J Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0910-2","volume":"19","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Han C.Y.; Duan F.G.; Fan X.X.; Yao X.J.; Parks R.J.; Tang Y.J.; Wang M.F.; Liu L.; Tsang B.K.; Leung E.L.; p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR\/PI3K\/AKT signaling. Cancer Cell Int Article number 1882019,19(1)","journal-title":"Cancer Cell Int"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-4-12","volume":"4","author":"Massion P.P.","year":"2003","unstructured":"Massion P.P.; Carbone D.P.; The molecular basis of lung cancer: Molecular abnormalities and therapeutic implications. Respir Res Article number 122003,4(1)","journal-title":"Respir Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"14S","DOI":"10.1378\/chest.109.3_Supplement.14S","volume":"109","author":"Devereux T.R.","year":"1996","unstructured":"Devereux T.R.; Taylor J.A.; Barrett J.C.; Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Giles F. Filley Lecture. Chest 1996,109(3)(Suppl.),14S-19S","journal-title":"Chest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cncy.22293","volume":"128","author":"Siemanowski J.","year":"2020","unstructured":"Siemanowski J.; Heydt C.; Merkelbach-Bruse S.; Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assurance. Cancer Cytopathol 2020,128(9),611-621","journal-title":"Cancer Cytopathol"},{"key":"ref=23","first-page":"445","volume":"7","author":"Hibi K.","year":"1992","unstructured":"Hibi K.; Takahashi T.; Yamakawa K.; Ueda R.; Sekido Y.; Ariyoshi Y.; Suyama M.; Takagi H.; Nakamura Y.; Takahashi T.; Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 1992,7(3),445-449","journal-title":"Oncogene"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1158\/1078-0432.CCR-09-0234","volume":"16","author":"Memmott R.M.","year":"2010","unstructured":"Memmott R.M.; Dennis P.A.; The role of the Akt\/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis. Clin Cancer Res 2010,16(1),4-10","journal-title":"Clin Cancer Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1378\/chest.07-2680","volume":"133","author":"Hodkinson P.S.","year":"2008","unstructured":"Hodkinson P.S.; Mackinnon A.; Sethi T.; Targeting growth factors in lung cancer. Chest 2008,133(5),1209-1216","journal-title":"Chest"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/carcin\/bgx039","volume":"38","author":"Xu X.","year":"2017","unstructured":"Xu X.; Chen W.; Leng S.; Padilla M.T.; Saxton B.; Hutt J.; Tessema M.; Kato K.; Kim K.C.; Belinsky S.A.; Lin Y.; Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop. Carcinogenesis 2017,38(6),604-614","journal-title":"Carcinogenesis"},{"key":"ref=27","first-page":"4077","volume":"11","author":"Li H.","year":"2019","unstructured":"Li H.; Zhang Q.; Wu Q.; Cui Y.; Zhu H.; Fang M.; Zhou X.; Sun Z.; Yu J.; Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway. Am J Transl Res 2019,11(7),4077-4088","journal-title":"Am J Transl Res"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116867","volume":"236","author":"Iqubal A.","year":"2019","unstructured":"Iqubal A.; Sharma S.; Najmi A.K.; Syed M.A.; Ali J.; Alam M.M.; Haque S.E.; Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- &#x3BA;B. Life Sci 2019,236","journal-title":"Life Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","volume":"218","author":"Iqubal A.","year":"2019","unstructured":"Iqubal A.; Iqubal M.K.; Sharma S.; Ansari M.A.; Najmi A.K.; Ali S.M.; Ali J.; Haque S.E.; Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision. Life Sci 2019,218,112-131","journal-title":"Life Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fonc.2020.00397","volume":"10","author":"Brassart-Pasco S.","year":"2020","unstructured":"Brassart-Pasco S.; Br&#xE9;zillon S.; Brassart B.; Ramont L.; Oudart J.B.; Monboisse J.C.; Tumor microenvironment: Extracellular matrix alterations influence tumor progression. Front Oncol 2020,10,397","journal-title":"Front Oncol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00210-019-01746-8","volume":"393","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Wang Q.; Wang Q.; Guo P.; Wang Y.; Xing Y.; Zhang M.; Liu F.; Zeng Q.; Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS\/HIF-1a\/VEGF signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 2020,393(3),469-480","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/CAD.0000000000000701","volume":"30","author":"Cao C.","year":"2019","unstructured":"Cao C.; Zhu L.; Chen Y.; Wang C.H.; ShenTu, J.Z.; Zheng, Y.L. Physalin B induces G2\/M cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by altering mitochondrial function. Anticancer Drugs 2019,30(2),128-137","journal-title":"Anticancer Drugs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.biopha.2017.10.164","volume":"97","author":"Sundarraj K.","year":"2018","unstructured":"Sundarraj K.; Raghunath A.; Perumal E.; A review on the chemotherapeutic potential of fisetin: in vitro evidences. Biomed Pharmacother 2018,97,928-940","journal-title":"Biomed Pharmacother"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.12962","volume":"43","author":"Hussain T.","year":"2019","unstructured":"Hussain T.; Al-Attas O.S.; Alamery S.; Ahmed M.; Odeibat H.A.M.; Alrokayan S.; The plant flavonoid, fisetin alle via tes cigarette smoke-induced oxidative stress, and inflammation in Wistar rat lungs. J Food Biochem 2019,43(8)","journal-title":"J Food Biochem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11626-014-9830-6","volume":"51","author":"Kang K.A.","year":"2015","unstructured":"Kang K.A.; Piao M.J.; Hyun J.W.; Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway. in vitro Cell. Dev Biol Anim 2015,51(3),300-309","journal-title":"Dev Biol Anim"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.3390\/ijms20174291","volume":"20","author":"Zanoaga O.","year":"2019","unstructured":"Zanoaga O.; Braicu C.; Jurj A.; Rusu A.; Buiga R.; Berindan-Neagoe I.; Progress in research on the role of flavonoids in lung Cancer. Int J Mol Sci 2019,20(17),4291","journal-title":"Int J Mol Sci"},{"key":"ref=37","first-page":"2667","volume":"15","author":"Wang J.","year":"2018","unstructured":"Wang J.; Huang S.; Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1\/2 pathway. Exp Ther Med 2018,15(3),2667-2673","journal-title":"Exp Ther Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cbi.2019.02.020","volume":"303","author":"Tabasum S.","year":"2019","unstructured":"Tabasum S.; Singh R.P.; Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition. Chem Biol Interact 2019,303,14-21","journal-title":"Chem Biol Interact"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3892\/ol.2016.4817","volume":"12","author":"Yang Y.","year":"2016","unstructured":"Yang Y.; Zang A.; Jia Y.; Shang Y.; Zhang Z.; Ge K.; Zhang J.; Fan W.; Wang B.; Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling. Oncol Lett 2016,12(3),2189-2193","journal-title":"Oncol Lett"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3389\/fphar.2019.01336","volume":"10","author":"Tuli H.S.","year":"2019","unstructured":"Tuli H.S.; Tuorkey M.J.; Thakral F.; Sak K.; Kumar M.; Sharma A.K.; Sharma U.; Jain A.; Aggarwal V.; Bishayee A.; Molecular mechanisms of action of genistein in cancer: Recent advances. Front Pharmacol 2019,10,1336","journal-title":"Front Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.biopha.2007.12.010","volume":"62","author":"Zou H.","year":"2008","unstructured":"Zou H.; Zhan S.; Cao K.; Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother 2008,62(9),583-589","journal-title":"Biomed Pharmacother"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1207\/S15327914NC330202","volume":"33","author":"Lian F.","year":"1999","unstructured":"Lian F.; Li Y.; Bhuiyan M.; Sarkar F.H.; p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer 1999,33(2),125-131","journal-title":"Nutr Cancer"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3892\/or.2015.4325","volume":"34","author":"Min J.","year":"2015","unstructured":"Min J.; Huang K.; Tang H.; Ding X.; Qi C.; Qin X.; Xu Z.; Xu Z.; Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1\/2 and p38 MAPK pathways. Oncol Rep 2015,34(6),2871-2879","journal-title":"Oncol Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3892\/ijo.2015.3304","volume":"48","author":"Ma L.","year":"2016","unstructured":"Ma L.; Wang R.; Nan Y.; Li W.; Wang Q.; Jin F.; Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases. Int J Oncol 2016,48(2),843-853","journal-title":"Int J Oncol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.15430\/JCP.2016.21.4.216","volume":"21","author":"Sung B.","year":"2016","unstructured":"Sung B.; Chung H.Y.; Kim N.D.; Role of apigenin in cancer prevention via the induction of apoptosis and autophagy. J Cancer Prev 2016,21(4),216-226","journal-title":"J Cancer Prev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-017-0179-x","volume":"7","author":"Yan X.","year":"2017","unstructured":"Yan X.; Qi M.; Li P.; Zhan Y.; Shao H.; Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci 2017,7,50","journal-title":"Cell Biosci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jff.2016.04.039","volume":"24","author":"Zhou X.","year":"2016","unstructured":"Zhou X.; Gao T.; Jiang X.G.; Xie M.L.; Protective effect of apigenin on bleomycin-induced pulmonary fibrosis in mice by increments of lung antioxidant ability and PPAR&#x3B3; expression. J Funct Foods 2016,24,382-389","journal-title":"J Funct Foods"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1016\/0169-5002(95)00434-3","volume":"12","author":"Ardizzoni A.","year":"1995","unstructured":"Ardizzoni A.; Camptothecin analogues in the treatment of non-small cell lung cancer. Lung Cancer 1995,12(Suppl. 1),S177-S185","journal-title":"Lung Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3892\/ijo.2018.4523","volume":"53","author":"Chiu Y.H.","year":"2018","unstructured":"Chiu Y.H.; Hsu S.H.; Hsu H.W.; Huang K.C.; Liu W.; Wu C.Y.; Huang W.P.; Chen J.Y.F.; Chen B.H.; Chiu C.C.; Human non small cell lung cancer cells can be sensitized to camptothecin by modulating autophagy. Int J Oncol 2018,53(5),1967-1979","journal-title":"Int J Oncol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1021\/mp900243b","volume":"7","author":"Venditto V.J.","year":"2010","unstructured":"Venditto V.J.; Simanek E.E.; Cancer therapies utilizing the camptothecins: A review of the in vivo literature. Mol Pharm 2010,7(2),307-349","journal-title":"Mol Pharm"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1023\/A:1026147812000","volume":"8","author":"S&#xE1;nchez-Alc&#xE1;zar J.A.","year":"2003","unstructured":"S&#xE1;nchez-Alc&#xE1;zar J.A.; Bradbury D.A.; Brea-Calvo G.; Navas P.; Knox A.J.; Camptothecin-induced apoptosis in non-small cell lung cancer is independent of cyclooxygenase expression. Apoptosis 2003,8(6),639-647","journal-title":"Apoptosis"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144462","volume":"10","author":"Tsai J.R.","year":"2015","unstructured":"Tsai J.R.; Liu P.L.; Chen Y.H.; Chou S.H.; Cheng Y.J.; Hwang J.J.; Chong I.W.; Curcumin inhibits non-small cell lung cancer cells metastasis through the adiponectin\/NF-&#x3BA;b\/MMPs signaling pathway. PLoS One 2015,10(12)","journal-title":"PLoS One"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.bbrc.2005.04.044","volume":"331","author":"Sen S.","year":"2005","unstructured":"Sen S.; Sharma H.; Singh N.; Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 2005,331(4),1245-1252","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/ijms17081352","volume":"17","author":"Amararathna M.","year":"2016","unstructured":"Amararathna M.; Johnston M.R.; Rupasinghe H.P.; Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci 2016,17(8),1352","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2018.00060","volume":"9","author":"Tang L.","year":"2018","unstructured":"Tang L.; Liu J.; Zhu L.; Chen Q.; Meng Z.; Sun L.; Hu J.; Ni Z.; Wang X.; Curcumin inhibits growth of human nci-h292 lung squamous cell carcinoma cells by increasing foxa2 expression. Front Pharmacol 2018,9,60","journal-title":"Front Pharmacol"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110441","volume":"129","author":"Xu H.","year":"2020","unstructured":"Xu H.; Wang L.; Shi B.; Hu L.; Gan C.; Wang Y.; Xiang Z.; Wang X.; Sheng J.; Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of &#x3B1;-tubulin acetylation. Biomed Pharmacother 2020,129","journal-title":"Biomed Pharmacother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.athoracsur.2015.05.074","volume":"100","author":"Reno T.A.","year":"2015","unstructured":"Reno T.A.; Kim J.Y.; Raz D.J.; Triptolide inhibits lung cancer cell migration, invasion, and metastasis. Ann Thorac Surg 2015,100(5),1817-1824","journal-title":"Ann Thorac Surg"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","volume":"40","author":"Noel P.","year":"2019","unstructured":"Noel P.; Von Hoff D.D.; Saluja A.K.; Velagapudi M.; Borazanci E.; Han H.; Triptolide and its derivatives as cancer therapies. Trends Pharmacol Sci 2019,40(5),327-341","journal-title":"Trends Pharmacol Sci"},{"key":"ref=59","first-page":"149","volume":"6","author":"Ziaei S.","year":"2016","unstructured":"Ziaei S.; Halaby R.; Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini review. Avicenna J Phytomed 2016,6(2),149-164","journal-title":"Avicenna J Phytomed"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"40800","DOI":"10.18632\/oncotarget.8315","volume":"7","author":"Liu T.","year":"2016","unstructured":"Liu T.; Liu X.; Li W.; Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget 2016,7(26),40800-40815","journal-title":"Oncotarget"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.biopha.2017.10.116","volume":"97","author":"Bhagya N.","year":"2018","unstructured":"Bhagya N.; Chandrashekar K.R.; Tetrandrine and cancer - an overview on the molecular approach. Biomed Pharmacother 2018,97,624-632","journal-title":"Biomed Pharmacother"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ptr.5809","volume":"31","author":"Kalalinia F.","year":"2017","unstructured":"Kalalinia F.; Karimi-Sani I.; Anticancer properties of solamargine: A systematic review. Phytother Res 2017,31(6),858-870","journal-title":"Phytother Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.febslet.2004.09.064","volume":"577","author":"Liu L.F.","year":"2004","unstructured":"Liu L.F.; Liang C.H.; Shiu L.Y.; Lin W.L.; Lin C.C.; Kuo K.W.; Action of solamargine on human lung cancer cells--enhancement of the susceptibility of cancer cells to TNFs. FEBS Lett 2004,577(1-2),67-74","journal-title":"FEBS Lett"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1007\/s13277-013-1433-4","volume":"35","author":"Lin Y.","year":"2014","unstructured":"Lin Y.; Xu J.; Liao H.; Li L.; Pan L.; Piperine induces apoptosis of lung cancer A549 cells via p53-dependent mitochondrial signaling pathway. Tumour Biol 2014,35(4),3305-3310","journal-title":"Tumour Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcell.2018.00010","volume":"6","author":"Rather R.A.","year":"2018","unstructured":"Rather R.A.; Bhagat M.; Cancer chemoprevention and piperine: Molecular mechanisms and therapeutic opportunities. Front Cell Dev Biol 2018,6,10","journal-title":"Front Cell Dev Biol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1023\/A:1021398601388","volume":"19","author":"Pradeep C.R.","year":"2002","unstructured":"Pradeep C.R.; Kuttan G.; Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin Exp Metastasis 2002,19(8),703-708","journal-title":"Clin Exp Metastasis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3892\/or.2013.2741","volume":"30","author":"Wei W.T.","year":"2013","unstructured":"Wei W.T.; Lin S.Z.; Liu D.L.; Wang Z.H.; The distinct mechanisms of the antitumor activity of emodin in different types of cancer. (Review) Oncol Rep [Review].2013,30(6),2555-2562","journal-title":"Oncol Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3892\/or.2017.5428","volume":"37","author":"Su J.","year":"2017","unstructured":"Su J.; Yan Y.; Qu J.; Xue X.; Liu Z.; Cai H.; Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3\/NF-&#x3BA;B pathway. Oncol Rep 2017,37(3),1565-1572","journal-title":"Oncol Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.34297\/AJBSR.2020.09.001375","volume":"9","author":"Ahmad B.","year":"2020","unstructured":"Ahmad B.; Su P.; Khan S.Z.; Wahid F.; Ullah H.; Ahmad M.; Hussain B.; Khan J.; Shah S.R.; Natural products (apigenin, curcumin and emodin) cure lung cancer. Am J Biomed Sci Res 2020,9(2),158-161","journal-title":"Am J Biomed Sci Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1008138230896","volume":"34","author":"Giri A.","year":"2000","unstructured":"Giri A.; Lakshmi Narasu M.; Production of podophyllotoxin from Podophyllum hexandrum: A potential natural product for clinically useful anticancer drugs. Cytotechnology 2000,34(1-2),17-26","journal-title":"Cytotechnology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3892\/ijo.2015.3123","volume":"47","author":"Choi J.Y.","year":"2015","unstructured":"Choi J.Y.; Hong W.G.; Cho J.H.; Kim E.M.; Kim J.; Jung C.H.; Hwang S.G.; Um H.D.; Park J.K.; Park J.K.; Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. Int J Oncol 2015,47(4),1257-1265","journal-title":"Int J Oncol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/etm.2012.580","volume":"4","author":"Zhong Z.","year":"2012","unstructured":"Zhong Z.; Dong Z.; Yang L.; Chen X.; Gong Z.; Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med 2012,4(2),267-272","journal-title":"Exp Ther Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0305-7372(95)90015-2","volume":"21","author":"Joel S.","year":"1996","unstructured":"Joel S.; The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use? Cancer Treat Rev 1996,21(6),513-525","journal-title":"Cancer Treat Rev"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105557","volume":"155","author":"Zhong Y.","year":"2020","unstructured":"Zhong Y.; Qi H.; Li X.; An M.; Shi Q.; Qi J.; Tumor supernatant derived from hepatocellular carcinoma cells treated with vincristine sulfate have therapeutic activity. Eur J Pharm Sci 2020,155","journal-title":"Eur J Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020401","volume":"21","author":"Costea T.","year":"2020","unstructured":"Costea T.; Vlad O.C.; Miclea L.C.; Ganea C.; Sz&#xF6;ll\u0151si J.; Mocanu M.M.; Alle via tion of multidrug resistance by flavonoid and non-flavonoid compounds in breast, lung, colorectal and prostate cancer. Int J Mol Sci ,Article number 401.2020,21(2)","journal-title":"Int J Mol Sci"},{"key":"ref=76","first-page":"1020","volume":"22","author":"Xia H.","year":"2018","unstructured":"Xia H.; Qu X.L.; Liu L.Y.; Qian D.H.; Jing H.Y.; LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy. Eur Rev Med Pharmacol Sci 2018,22(4),1020-1027","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.7314\/APJCP.2013.14.4.2325","volume":"14","author":"Xu T.P.","year":"2013","unstructured":"Xu T.P.; Shen H.; Liu L.X.; Shu Y.Q.; Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- &#x3BA;B inactivation. Asian Pac J Cancer Prev 2013,14(4),2325-2331","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.intimp.2017.12.021","volume":"55","author":"Yu T.","year":"2018","unstructured":"Yu T.; Xu Y.Y.; Zhang Y.Y.; Li K.Y.; Shao Y.; Liu G.; Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6\/STAT3 signaling in vitro. Int Immunopharmacol 2018,55,290-296","journal-title":"Int Immunopharmacol"},{"key":"ref=79","first-page":"785","volume":"28","author":"Gomathinayagam R.","year":"2008","unstructured":"Gomathinayagam R.; Sowmyalakshmi S.; Mardhatillah F.; Kumar R.; Akbarsha M.A.; Damodaran C.; Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res 2008,28(2A),785-792","journal-title":"Anticancer Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.lungcan.2011.12.013","volume":"76","author":"Xue X.","year":"2012","unstructured":"Xue X.; Sun D.F.; Sun C.C.; Liu H.P.; Yue B.; Zhao C.R.; Lou H.X.; Qu X.J.; Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies. Lung Cancer 2012,76(3),300-308","journal-title":"Lung Cancer"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejphar.2011.06.013","volume":"667","author":"Sun C.C.","year":"2011","unstructured":"Sun C.C.; Zhang Y.S.; Xue X.; Cheng Y.N.; Liu H.P.; Zhao C.R.; Lou H.X.; Qu X.J.; Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. Eur J Pharmacol 2011,667(1-3),136-143","journal-title":"Eur J Pharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.biopha.2018.06.159","volume":"106","author":"Imran M.","year":"2018","unstructured":"Imran M.; Rauf A.; Khan I.A.; Shahbaz M.; Qaisrani T.B.; Fatmawati S.; Abu-Izneid T.; Imran A.; Rahman K.U.; Gondal T.A.; Thymoquinone: A novel strategy to combat cancer: A review. Biomed Pharmacother 2018,106,390-402","journal-title":"Biomed Pharmacother"},{"key":"ref=83","first-page":"260","volume":"6","author":"Nithya G.","year":"2014","unstructured":"Nithya G.; Mani R.; Sakthisekaran D.; Oral administration of thymoquinone attenuates benzo (a) pyrene induced lung carcinogenesis in male Swiss albino mice. Int J Pharm Pharm Sci 2014,6,260-263","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13659-018-0162-1","volume":"8","author":"Zhang Y.","year":"2018","unstructured":"Zhang Y.; Xu G.; Zhang S.; Wang D.; Saravana Prabha P.; Zuo Z.; Antitumor research on artemisinin and its bioactive derivatives. Nat Prod Bioprospect 2018,8(4),303-319","journal-title":"Nat Prod Bioprospect"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"31413","DOI":"10.18632\/oncotarget.8920","volume":"7","author":"Tong Y.","year":"2016","unstructured":"Tong Y.; Liu Y.; Zheng H.; Zheng L.; Liu W.; Wu J.; Ou R.; Zhang G.; Li F.; Hu M.; Liu Z.; Lu L.; Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt\/&#x3B2;-catenin signaling. Oncotarget 2016,7(21),31413-31428","journal-title":"Oncotarget"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.phymed.2018.09.167","volume":"52","author":"Rassias D.J.","year":"2019","unstructured":"Rassias D.J.; Weathers P.J.; Dried leaf Artemisia annua efficacy against non-small cell lung cancer. Phytomedicine 2019,52,247-253","journal-title":"Phytomedicine"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-018-0902-4","volume":"37","author":"Chen C.","year":"2018","unstructured":"Chen C.; Shenoy A.K.; Padia R.; Fang D.; Jing Q.; Yang P.; Su S.B.; Huang S.; Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2\u2032, 4\u2032-Tetrahydroxychalcone. J Exp Clin Cancer Res 2018,37(1),243","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3892\/ijo.2014.2320","volume":"44","author":"Gong W.Y.","year":"2014","unstructured":"Gong W.Y.; Wu J.F.; Liu B.J.; Zhang H.Y.; Cao Y.X.; Sun J.; Lv Y.B.; Wu X.; Dong J.C.; Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro. Int J Oncol 2014,44(5),1561-1570","journal-title":"Int J Oncol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1142\/S0192415X19500459","volume":"47","author":"Zhou W.","year":"2019","unstructured":"Zhou W.; Wu Y.; Pan M.; Liu D.; Liu B.; Proliferation and migration of lung cancer could be inhibited by oxymatrine through the regulation for miR-520\/VEGF. Am J Chin Med 2019,47(4),865-878","journal-title":"Am J Chin Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bbrc.2016.07.037","volume":"477","author":"Mohan V.","year":"2016","unstructured":"Mohan V.; Agarwal R.; Singh R.P.; A novel alkaloid, evodiamine causes nuclear localization of cytochrome-C and induces apoptosis independent of p53 in human lung cancer cells. Biochem Biophys Res Commun 2016,477(4),1065-1071","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-015-2406-2","volume":"405","author":"Chatterjee P.","year":"2015","unstructured":"Chatterjee P.; Seal S.; Mukherjee S.; Kundu R.; Bhuyan M.; Barua N.C.; Baruah P.K.; Babu S.P.; Bhattacharya S.; A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells. Mol Cell Biochem 2015,405(1-2),149-158","journal-title":"Mol Cell Biochem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12010048","volume":"12","author":"Ong C.P.","year":"2019","unstructured":"Ong C.P.; Lee W.L.; Tang Y.Q.; Yap W.H.; Honokiol: A review of its anticancer potential and mechanisms. Cancers (Basel) 2019,12(1),1-44","journal-title":"Cancers (Basel)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1158\/1940-6207.CAPR-16-0129","volume":"10","author":"Pan J.","year":"2017","unstructured":"Pan J.; Lee Y.; Zhang Q.; Xiong D.; Wan T.C.; Wang Y.; You M.; Honokiol decreases lung cancer metastasis through inhibition of the STAT3 signaling pathway. Cancer Prev Res (Phila) 2017,10(2),133-141","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.7150\/jca.34374","volume":"11","author":"Rizeq B.","year":"2020","unstructured":"Rizeq B.; Gupta I.; Ilesanmi J.; AlSafran M.; Rahman M.M.; Ouhtit A.; The power of phytochemicals combination in cancer chemoprevention. J Cancer 2020,11(15),4521-4533","journal-title":"J Cancer"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1574892809666140619154838","volume":"9","author":"Ho J.W.S.","year":"2014","unstructured":"Ho J.W.S.; Cheung M.W.M.; Combination of phytochemicals as adjuvants for cancer therapy. Rec Pat Anticancer Drug Discov 2014,9(3),297-302","journal-title":"Rec Pat Anticancer Drug Discov"},{"key":"ref=96","first-page":"2045","volume":"7","author":"Zhuo W.","year":"2015","unstructured":"Zhuo W.; Zhang L.; Zhu Y.; Zhu B.; Chen Z.; Fisetin, a dietary bioflavonoid, reverses acquired cisplatin-resistance of lung adenocarcinoma cells through MAPK\/Survivin\/Caspase pathway. Am J Transl Res 2015,7(10),2045-2052","journal-title":"Am J Transl Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2008.03.052","volume":"269","author":"Banerjee S.","year":"2008","unstructured":"Banerjee S.; Li Y.; Wang Z.; Sarkar F.H.; Multi-targeted therapy of cancer by genistein. Cancer Lett 2008,269(2),226-242","journal-title":"Cancer Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24020278","volume":"24","author":"Choi B.Y.","year":"2019","unstructured":"Choi B.Y.; Biochemical basis of anti-cancer-effects of phloretin-A natural dihydrochalcone. Molecules 2019,24(2),1-14","journal-title":"Molecules"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2407-5-10","volume":"5","author":"Yumuk P.F.","year":"2005","unstructured":"Yumuk P.F.; Turhal N.S.; Gumus M.; Hatabay N.F.; Turken O.; Ozkan A.; Salepci T.; Aliustaoglu M.; Ahiskali R.; Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer. BMC Cancer 2005,5(1),10","journal-title":"BMC Cancer"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1556-0864(15)31529-X","volume":"1","author":"Chen Y.M.","year":"2006","unstructured":"Chen Y.M.; Perng R.P.; Tsai C.M.; Whang-Peng J.; A Phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly. J Thorac Oncol 2006,1(2),141-145","journal-title":"J Thorac Oncol"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.59566\/IJBS.2012.8028","volume":"8","author":"Liu W.","year":"2012","unstructured":"Liu W.; Zhang J.; Ying C.; Wang Q.; Yan C.; Jingyue Y.; Zhaocai Y.; Yan X.; Heng-Jun S.; Lin J.; Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy. Int J Biomed Sci 2012,8(1),28-35","journal-title":"Int J Biomed Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-29-87","volume":"29","author":"Jafri S.H.","year":"2010","unstructured":"Jafri S.H.; Glass J.; Shi R.; Zhang S.; Prince M.; Kleiner-Hancock H.; Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. J Exp Clin Cancer Res 2010,29(1),87","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/10717544.2021.1927245","volume":"28","author":"Rahat I.","year":"2021","unstructured":"Rahat I.; Imam S.S.; Rizwanullah M.; Alshehri S.; Asif M.; Kala C.; Taleuzzaman M.; Thymoquinone-entrapped chitosan-modified nanoparticles: Formulation optimization to preclinical bioavailability assessments. Drug Deliv 2021,28(1),973-984","journal-title":"Drug Deliv"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.2147\/IJN.S259628","volume":"15","author":"Dhupal M.","year":"2020","unstructured":"Dhupal M.; Chowdhury D.; Phytochemical-based nanomedicine for advanced cancer theranostics: Perspectives on clinical trials to clinical use. Int J Nanomedicine 2020,15,9125-9157","journal-title":"Int J Nanomedicine"},{"key":"ref=105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102565","volume":"64","author":"Rahat I.","year":"2021","unstructured":"Rahat I.; Rizwanullah M.; Gilani S.J.; Jummah M.B.; Imam S.S.; Kala C.; Asif M.; Alshehri S.; Sharma S.K.; Thymoquinone loaded chitosan-solid lipid nanoparticles: Formulation optimization to oral bioavailability study. J Drug Deliv Sci Technol 2021,64","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2174\/1381612823666170124111142","volume":"23","author":"Ahmad J.","year":"2017","unstructured":"Ahmad J.; Singhal M.; Amin S.; Rizwanullah M.; Akhter S.; Kamal M.A.; Haider N.; Midoux P.; Pichon C.; Bile salt stabilized vesicles (bilosomes): A novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr Pharm Des 2017,23(11),1575-1588","journal-title":"Curr Pharm Des"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101634","volume":"57","author":"Saifi Z.","year":"2020","unstructured":"Saifi Z.; Rizwanullah M.; Mir S.R.; Amin S.; Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment. J Drug Deliv Sci Technol 2020,57","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1201\/9780367821678-11","volume":"1","author":"Rizwanullah M.","year":"2020","unstructured":"Rizwanullah M.; Rizvi M.M.A.; Amin S.; Pharmaceutical drug product development and process optimization: Effective use of quality by design; Beg, S.; Rahman, M.; Imam, S.S.; Alruwaili, N.K.; Al Robaian, M.; Panda, S.K., Eds.; 2020,1,309-332","journal-title":"Pharmaceutical drug product development and process optimization: Effective use of quality by design;"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/2468187309666190514083508","volume":"10","author":"Rizwanullah M.","year":"2020","unstructured":"Rizwanullah M.; Ahmad J.; Amin S.; Mishra A.; Ain M.R.; Rahman M.; Polymer-lipid hybrid systems: Scope of intravenous-to-Oral switch in Cancer chemotherapy. Curr Nanomed 2020,10,164-177","journal-title":"Curr Nanomed"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.ijbiomac.2020.09.185","volume":"163","author":"Shahab M.S.","year":"2020","unstructured":"Shahab M.S.; Rizwanullah M.; Alshehri S.; Imam S.S.; Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: in vitro, ex vivo and toxicity assessments. Int J Biol Macromol 2020,163,2392-2404","journal-title":"Int J Biol Macromol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1208\/s12249-019-1304-4","volume":"20","year":"2019","unstructured":"Harshita; Barkat, M.A.; Rizwanullah, M.; Beg, S.; Pottoo, F.H.; Siddiqui, S.; Ahmad, F.J. Paclitaxel-loaded nanolipidic carriers with improved oral bioavailability and anticancer activity against human liver carcinoma. AAPS PharmSciTech 2019,20(2),87","journal-title":"AAPS PharmSciTech"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1574891X13666180911095440","volume":"13","author":"Gilani S.J.","year":"2018","unstructured":"Gilani S.J.; Jahangir M.A.; Chandrakala; Rizwanullah, M.; Taleuzzaman, M.; Shahab, M.S.; Shakeel, K.; Aqil, M.; Imam, S.S. Nano-based therapy for treatment of skin cancer. Rec Pat Antiinfect Drug Discov 2018,13(2),151-163","journal-title":"Rec Pat Antiinfect Drug Discov"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/coatings11010006","volume":"11","author":"Alshehri S.","year":"2021","unstructured":"Alshehri S.; Imam S.S.; Rizwanullah M.; Fakhri K.U.; Rizvi M.M.A.; Mahdi W.; Kazi M.; Effect of chitosan coating on plga nanoparticles for oral delivery of thymoquinone: in vitro, ex vivo, and cancer cell line assessments. Coatings 2021,11,6","journal-title":"Coatings"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/a-1296-7870","volume":"71","author":"Akhter M.H.","year":"2021","unstructured":"Akhter M.H.; Rizwanullah M.; Ahmad J.; Amin S.; Ahmad M.Z.; Minhaj M.A.; Mujtaba M.A.; Ali J.; Molecular targets and nanoparticulate systems designed for the improved therapeutic intervention in glioblastoma multiforme. Drug Res (Stuttg) 2021,71(3),122-137","journal-title":"Drug Res (Stuttg)"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1567201812666150817124133","volume":"13","author":"Rizwanullah M.","year":"2016","unstructured":"Rizwanullah M.; Ahmad J.; Amin S.; Nanostructured lipid carriers: A novel platform for chemotherapeutics. Curr Drug Deliv 2016,13(1),4-26","journal-title":"Curr Drug Deliv"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/21691401.2017.1366333","volume":"46","author":"Akhter M.H.","year":"2018","unstructured":"Akhter M.H.; Rizwanullah M.; Ahmad J.; Ahsan M.J.; Mujtaba M.A.; Amin S.; Nanocarriers in advanced drug targeting: Setting novel paradigm in cancer therapeutics. Artif Cells Nanomed Biotechnol 2018,46(5),873-884","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=117","first-page":"55","volume":"8","author":"Ahmad J.","year":"2015","unstructured":"Ahmad J.; Akhter S.; Rizwanullah M.; Amin S.; Rahman M.; Ahmad M.Z.; Rizvi M.A.; Kamal M.A.; Ahmad F.J.; Nanotechnology-based inhalation treatments for lung cancer: State of the art. Nanotechnol Sci Appl 2015,8,55-66","journal-title":"Nanotechnol Sci Appl"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2174\/1381612826666200318170716","volume":"26","author":"Haider N.","year":"2020","unstructured":"Haider N.; Fatima S.; Taha M.; Rizwanullah M.; Firdous J.; Ahmad R.; Mazhar F.; Khan M.A.; Nanomedicines in diagnosis and treatment of cancer: An update. Curr Pharm Des 2020,26(11),1216-1231","journal-title":"Curr Pharm Des"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0929867327666201104151752","volume":"28","author":"Iqubal M.K.","year":"2020","unstructured":"Iqubal M.K.; Chaudhuri A.; Iqubal A.; Saleem S.; Gupta M.M.; Ahuja A.; Ali J.; Baboota S.; Targeted delivery of natural bioactives and lipid-nanocargos against signaling pathways involved in skin cancer. Curr Med Chem 2020,28,1-15","journal-title":"Curr Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/1061186X.2016.1191080","volume":"25","author":"Rizwanullah M.","year":"2017","unstructured":"Rizwanullah M.; Amin S.; Ahmad J.; Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. J Drug Target 2017,25(1),58-74","journal-title":"J Drug Target"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/21691401.2017.1408124","author":"Soni K.","year":"2018","unstructured":"Soni K.; Rizwanullah M.; Kohli K.; Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: In vitro, ex vivo and in vivo assessments Artif Cells Nanomed Biotechnol 2018(46)(sup1),15-31","journal-title":"In vitro, ex vivo and in vivo assessments Artif Cells Nanomed Biotechnol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2174\/1389200221666200719003304","volume":"21","author":"Ahmad J.","year":"2020","unstructured":"Ahmad J.; Rizwanullah M.; Amin S.; Warsi M.H.; Ahmad M.Z.; Barkat M.A.; Nanostructured lipid carriers (NLCs): Nose-to-brain delivery and theranostic application. Curr Drug Metab 2020,21(14),1136-1143","journal-title":"Curr Drug Metab"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jddst.2019.03.008","volume":"51","author":"Mahtab A.","year":"2019","unstructured":"Mahtab A.; Rizwanullah M.; Pandey S.; Leekha A.; Rabbani S.A.; Verma A.K.; Aqil M.; Talegaonkar S.; Quality by design driven development and optimization of Teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments. J Drug Deliv Sci Technol 2019,51,383-396","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2174\/1381612826666200317140600","volume":"26","author":"Barkat M.A.","year":"2020","unstructured":"Barkat M.A.; Harshita, Rizwanullah, M.; Pottoo, F.H.; Beg, S.; Akhter, S.; Ahmad, F.J. Therapeutic nanoemulsion: Concept to delivery. Curr Pharm Des 2020,26(11),1145-1166","journal-title":"Curr Pharm Des"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/02652048.2020.1767223","volume":"37","author":"Yousefian Rad E.","year":"2020","unstructured":"Yousefian Rad E.; Homayouni Tabrizi M.; Ardalan P.; Seyedi S.M.R.; Yadamani S.; Zamani-Esmati P.; Haghani Sereshkeh N.; Citrus lemon Essential Oil Nanoemulsion (CLEO-NE), a safe cell-depended apoptosis inducer in human A549 lung cancer cells with anti-angiogenic activity. J Microencapsul 2020,37(5),394-402","journal-title":"J Microencapsul"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/ph13070152","volume":"13","author":"Md S.","year":"2020","unstructured":"Md S.; Alhakamy N.A.; Aldawsari H.M.; Husain M.; Kotta S.; Abdullah S.T.A.; Fahmy U.; Alfaleh M.A.; Asfour H.Z.; Formulation design, statistical optimization, and in vitro evaluation of a naringenin nanoemulsion to enhance apoptotic activity in a549 lung cancer cells. Pharmaceuticals (Basel) 2020,13(7),152","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=127","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102261","volume":"29","author":"Xie X.","year":"2020","unstructured":"Xie X.; Li Y.; Zhao D.; Fang C.; He D.; Yang Q.; Yang L.; Chen R.; Tan Q.; Zhang J.; Oral administration of natural polyphenol-loaded natural polysaccharide-cloaked lipidic nanocarriers to improve efficacy against small-cell lung cancer. Nanomedicine (Lond) 2020,29","journal-title":"Nanomedicine (Lond)"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.2147\/OTT.S169555","volume":"11","author":"Zhou X.","year":"2018","unstructured":"Zhou X.; Liu H.Y.; Zhao H.; Wang T.; RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment. OncoTargets Ther 2018,11,5397-5405","journal-title":"OncoTargets Ther"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.apsb.2018.03.004","volume":"8","author":"Zhang T.","year":"2018","unstructured":"Zhang T.; Chen Y.; Ge Y.; Hu Y.; Li M.; Jin Y.; Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers. Acta Pharm Sin B 2018,8(3),440-448","journal-title":"Acta Pharm Sin B"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.2147\/IJN.S140096","volume":"12","author":"Jin X.","year":"2017","unstructured":"Jin X.; Yang Q.; Zhang Y.; Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: Implications for effective treatment of lung cancer. Int J Nanomedicine 2017,12,5109-5118","journal-title":"Int J Nanomedicine"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2013.01.050","volume":"444","author":"Seguin J.","year":"2013","unstructured":"Seguin J.; Brull&#xE9; L.; Boyer R.; Lu Y.M.; Ramos Romano M.; Touil Y.S.; Scherman D.; Bessodes M.; Mignet N.; Chabot G.G.; Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. Int J Pharm 2013,444(1-2),146-154","journal-title":"Int J Pharm"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1016\/j.msec.2013.07.047","volume":"33","author":"Wang P.","year":"2013","unstructured":"Wang P.; Zhang L.; Peng H.; Li Y.; Xiong J.; Xu Z.; The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C 2013,33(8),4802-4808","journal-title":"Mater Sci Eng C"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/jcp.29126","volume":"235","author":"Aghebati-Maleki A.","year":"2020","unstructured":"Aghebati-Maleki A.; Dolati S.; Ahmadi M.; Baghbanzhadeh A.; Asadi M.; Fotouhi A.; Yousefi M.; Aghebati-Maleki L.; Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol 2020,235(3),1962-1972","journal-title":"J Cell Physiol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2174\/1381612826666200116150426","volume":"26","author":"Rizwanullah M.","year":"2020","unstructured":"Rizwanullah M.; Alam M.; Harshita, Mir, S.R.; Rizvi, M.M.A.; Amin, S. Polymer-lipid hybrid nanoparticles: A next-generation nanocarrier for targeted treatment of solid tumors. Curr Pharm Des 2020,26(11),1206-1215","journal-title":"Curr Pharm Des"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.2174\/1567205014666170508121031","volume":"14","author":"Ahmad J.","year":"2017","unstructured":"Ahmad J.; Akhter S.; Rizwanullah M.; Khan M.A.; Pigeon L.; Addo R.T.; Greig N.H.; Midoux P.; Pichon C.; Kamal M.A.; Nanotechnology based theranostic approaches in alzheimer\u2019s disease management: Current status and future perspective. Curr Alzheimer Res 2017,14(11),1164-1181","journal-title":"Curr Alzheimer Res"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.2147\/IJN.S243657","volume":"15","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Chen W.; Tu G.; Chen X.; Lu Y.; Wu L.; Zheng D.; Enhanced chemotherapeutic efficacy of plga-encapsulated epigallocatechin gallate (egcg) against human lung cancer. Int J Nanomedicine 2020,15,4417-4429","journal-title":"Int J Nanomedicine"},{"key":"ref=137","first-page":"231","volume":"9","author":"Xu H.","year":"2014","unstructured":"Xu H.; Hou Z.; Zhang H.; Kong H.; Li X.; Wang H.; Xie W.; An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(&#x3B5;-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. Int J Nanomedicine 2014,9,231-242","journal-title":"Int J Nanomedicine"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/coatings10050439","volume":"10","author":"Aldawsari H.M.","year":"2020","unstructured":"Aldawsari H.M.; Alhakamy N.A.; Padder R.; Husain M.; Md S.; Preparation and characterization of chitosan coated plga nanoparticles of resveratrol: Improved stability, antioxidant and apoptotic activities in h1299 lung cancer cells. Coatings 2020,10(5),439","journal-title":"Coatings"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.sjbs.2020.05.023","volume":"27","author":"Ahmad N.","year":"2020","unstructured":"Ahmad N.; Ahmad R.; Alrasheed R.A.; Almatar H.M.A.; Al-Ramadan A.S.; Buheazah T.M.; AlHomoud H.S.; Al-Nasif H.A.; Alam M.A.; A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment. Saudi J Biol Sci 2020,27(9),2344-2357","journal-title":"Saudi J Biol Sci"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10904-020-01672-w","volume":"31","author":"Al-Kinani M.A.","year":"2021","unstructured":"Al-Kinani M.A.; Haider A.J.; Al-Musawi S.; Design, construction and characterization of intelligence polymer coated core-shell nanocarrier for curcumin drug encapsulation and delivery in lung cancer therapy purposes. J Inorg Organomet Polym Mater 2021,31,1-10","journal-title":"J Inorg Organomet Polym Mater"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1166\/jbn.2016.2162","volume":"12","author":"Lee W.H.","year":"2016","unstructured":"Lee W.H.; Loo C.Y.; Ong H.X.; Traini D.; Young P.M.; Rohanizadeh R.; Synthesis and characterization of inhalable flavonoid nanoparticle for lung cancer cell targeting. J Biomed Nanotechnol 2016,12(2),371-386","journal-title":"J Biomed Nanotechnol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejbas.2017.11.002","volume":"5","author":"Kumar N.","year":"2018","unstructured":"Kumar N.; Salar R.K.; Prasad M.; Ranjan K.; Synthesis, characterization and anti-cancer activity of vincristine loaded folic acid-chitosan conjugated nanoparticles on NCI-H460 non-small cell lung cancer cell line. Egyptian J Basic Appl Sci 2018,5(1),87-99","journal-title":"Egyptian J Basic Appl Sci"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.etap.2016.07.006","volume":"46","author":"Das J.","year":"2016","unstructured":"Das J.; Samadder A.; Mondal J.; Abraham S.K.; Khuda-Bukhsh A.R.; Nano-encapsulated chlorophyllin significantly delays progression of lung cancer both in in vitro and in vivo models through activation of mitochondrial signaling cascades and drug-DNA interaction. Environ Toxicol Pharmacol 2016,46,147-157","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/molecules25081913","volume":"25","author":"Rudnik L.A.C.","year":"2020","unstructured":"Rudnik L.A.C.; Farago P.V.; Manfron Budel J.; Lyra A.; Barboza F.M.; Klein T.; Kanunfre C.C.; Nadal J.M.; Band&#xE9;ca M.C.; Raman V.; Novatski A.; Logu&#xE9;rcio A.D.; Zanin S.M.W.; Co-loaded curcumin and methotrexate nanocapsules enhance cytotoxicity against non-small-cell lung cancer cells. Molecules 2020,25(8),1913","journal-title":"Molecules"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/02652048.2016.1156175","volume":"33","author":"Shi C.","year":"2016","unstructured":"Shi C.; Zeng F.; Fu D.; Surfactant-free poly(lactide-co-glycolide) nanoparticles for improving in vitro anticancer efficacy of tetrandrine. J Microencapsul 2016,33(3),249-256","journal-title":"J Microencapsul"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/03639045.2018.1472277","volume":"44","author":"Ding Y.","year":"2018","unstructured":"Ding Y.; Wang C.; Wang Y.; Xu Y.; Zhao J.; Gao M.; Ding Y.; Peng J.; Li L.; Development and evaluation of a novel drug delivery: Soluplus&#xAE;\/TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Dev Ind Pharm 2018,44(9),1409-1416","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/ijerph13121182","volume":"13","author":"Wang F.","year":"2016","unstructured":"Wang F.; Li C.; Cheng J.; Yuan Z.; Recent advances on inorganic nanoparticle-based cancer therapeutic agents. Int J Environ Res Public Health 2016,13(12),1182","journal-title":"Int J Environ Res Public Health"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/17458080.2020.1761014","volume":"15","author":"Suresh S.","year":"2020","unstructured":"Suresh S.; Muthukrishnan L.; Vennila S.; Paiman S.; Faruq M.; Al-Lohedan H.A.; Akbarzadeh O.; Oh W.C.; Mechanistic anticarcinogenic efficacy of phytofabricated gold nanoparticles on human lung adenocarcinoma cells. J Exp Nanosci 2020,15(1),160-173","journal-title":"J Exp Nanosci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.msec.2018.07.053","volume":"92","author":"Dadashpour M.","year":"2018","unstructured":"Dadashpour M.; Firouzi-Amandi A.; Pourhassan-Moghaddam M.; Maleki M.J.; Soozangar N.; Jeddi F.; Nouri M.; Zarghami N.; Pilehvar-Soltanahmadi Y.; Biomimetic synthesis of silver nanoparticles using matricaria chamomilla extract and their potential anticancer activity against human lung cancer cells. Mater Sci Eng C 2018,92,902-912","journal-title":"Mater Sci Eng C"},{"key":"ref=150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2019.111728","volume":"203","author":"Saravanakumar K.","year":"2020","unstructured":"Saravanakumar K.; Jeevithan E.; Hu X.; Chelliah R.; Oh D.H.; Wang M.H.; Enhanced anti-lung carcinoma and anti-biofilm activity of fungal molecules mediated biogenic zinc oxide nanoparticles conjugated with &#x3B2;-D-glucan from barley. J Photochem Photobiol B 2020,203","journal-title":"J Photochem Photobiol B"},{"key":"ref=151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2020.101698","volume":"27","author":"Bharathi D.","year":"2020","unstructured":"Bharathi D.; Preethi S.; Abarna K.; Nithyasri M.; Kishore P.; Deepika K.; Bio-inspired synthesis of Flower Shaped Iron Oxide Nanoparticles (FeONPs) using phytochemicals of Solanum lycopersicum leaf extract for biomedical applications. Biocatal Agric Biotechnol 2020,27","journal-title":"Biocatal Agric Biotechnol"},{"key":"ref=152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109561","volume":"125","author":"Song Y.","year":"2020","unstructured":"Song Y.; Zhou B.; Du X.; Wang Y.; Zhang J.; Ai Y.; Xia Z.; Zhao G.; Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on Non-Small Cell Lung Cancer (NSCLC). Biomed Pharmacother 2020,125","journal-title":"Biomed Pharmacother"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejps.2016.09.019","volume":"96","author":"Stolarczyk E.U.","year":"2017","unstructured":"Stolarczyk E.U.; Stolarczyk K.; \u0141aszcz M.; Kubiszewski M.; Maruszak W.; Olejarz W.; Bryk D.; Synthesis and characterization of genistein conjugated with gold nanoparticles and the study of their cytotoxic properties. Eur J Pharm Sci 2017,96,176-185","journal-title":"Eur J Pharm Sci"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210708123750","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194620\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666210708123750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:29:56Z","timestamp":1725391796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194620\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666210708123750","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}